Profile of Mecasermin for the Long-Term Treatment of Growth Failure in Children and Adolescents With Severe Primary IGF-1 Deficiency

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s6178
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search